19 completed. 19 Phase 2, 3 Phase 1, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 19 | Completed 19 |
| Phase 1 | 3 | Completed 3 |
| Phase 3 | 3 | Completed 3 |
Follow Corticosteroid: new trials by email Literature Review of Corticosteroid trials Research Report on Corticosteroid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treating Exacerbations of Asthma With Oral Montelukast in Children Montelukast Oral Granules, Albuterol, Corticosteroid - Status Asthmaticus | Phase 2 | Completed | Vanderbilt University Medical Center | 90 | 2023-10-20 | 2026-07-02 |
| Intraarticular Leukocyte-rich and Leukocyte-poor PRP for Osteoarthritis of the Knee Leukocyte-rich platelet-rich plasma, Leukocyte-poor platelet-rich plasma, Corticosteroid - Osteo Arthritis Knee | Phase 2 / Phase 3 | Completed | Queen Savang Vadhana Memorial Hospital, Thailand | 93 | 2020-08-03 | 2023-02-21 |
| First Line Therapy for High Risk Acute GVHD Ruxolitinib, Corticosteroid - aGVHD, Stem Cell Transplant Complications | Phase 2 | Completed | Chinese PLA General Hospital | 198 | 2019-08-25 | 2023-11-29 |
| Safety and Tolerability of ISX (Isoxsuprine HCL) in MS Relapses Isoxsuprine Hydrochloride, Placebo, Corticosteroid - Multiple Sclerosis | Phase 1 / Phase 2 | Completed | University of New Mexico | 2 | 2019-02-15 | 2024-02-06 |
| Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis Sirolimus, Corticosteroid - Retroperitoneal Fibrosis | Phase 2 / Phase 3 | Completed | Peking University International Hospital | 64 | 2018-07-01 | 2026-09-22 |
| Comparison of Methylprednisolone or Methotrexate in the Maintenance Treatment of Nasal Polyposis Emthexate, Prednol, Mometasone Furoate - Nasal Polyposis | Phase 2 | Completed | Dokuz Eylul University | 41 | 2017-09-02 | 2020-08-31 |
| Safety and Efficacy of Blinatumomab in Adults With Newly Diagnosed High-risk Diffuse Large B-Cell Lymphoma Blinatumomab, Investigator's Choice Chemotherapy, Dexamethasone - High-risk Diffuse Large B-Cell Lymphoma | Phase 2 | Completed | Amgen | 47 | 2017-03-13 | 2020-09-14 |
| A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma Durvalumab, Rituximab, Doxorubicin - Lymphoma, Large B-Cell, Diffuse | Phase 2 | Completed | Celgene | 46 | 2017-02-28 | 2023-05-22 |
| A Study of Durvalumab in Combination With Lenalidomide With and Without Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Durvalumab, Lenalidomide, Dexamethasone - Multiple Myeloma | Phase 1 / Phase 2 | Completed | Celgene | 56 | 2016-04-25 | 2023-10-06 |
| Biomarkers of Irritant-Induced and Allergic Asthma Fluticasone propionate HFA 220 - Asthma | Phase 2 | Completed | NYU Langone Health | 18 | 2013-12-01 | 2021-09-13 |
| Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis triamcinolone acetonide (Triesence®) - Uveitis, Intermediate Uveitis | Phase 1 / Phase 2 | Completed | Clearside Biomedical, Inc. | 11 | 2013-02-01 | 2021-02-21 |
| Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma bevacizumab, Corticosteroid - Nasopharyngeal Carcinoma, Adverse Effect of Radiation Therapy | Phase 2 | Completed | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 112 | 2012-06-01 | 2019-01-09 |
| Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) High Dose Methylprednisolone (HDMP), Ofatumumab, Lenalidomide - Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 29 | 2012-01-26 | 2021-04-27 |
| Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer Abiraterone acetate, Dutasteride, Prednisone - Prostate Cancer | Phase 2 | Completed | Mary-Ellen Taplin, MD | 40 | 2011-09-01 | 2018-03-15 |
| Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Rituximab, Placebo, CMRI - Systemic Sclerosis-Associated PAH | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 57 | 2011-06-24 | 2023-02-21 |
| Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma Propranolol, Prednisone - Hemangioma | Phase 2 | Completed | University of Sao Paulo | 50 | 2010-01-01 | 2014-12-02 |
| A Study of the Correlation Between Pharmacokinetic and Pharmacodynamic Parameters of CellCept (Mycophenolate Mofetil). mycophenolate mofetil, antibody induction, Cyclosporine - Kidney Transplantation | Phase 2 | Completed | Hoffmann-La Roche | 45 | 2006-12-01 | 2016-05-12 |
| Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant Rejection Thymoglobulin, Corticosteroid, Tacrolimus - Liver Dysfunction, Rejection, Transplant | Phase 2 | Completed | Genzyme, a Sanofi Company | 75 | 2005-04-01 | 2015-03-18 |
| Deflazacort in Dysferlinopathies deflazacort, placebo - LGMD2B, Miyoshi Myopathy | Phase 2 / Phase 3 | Completed | Ludwig-Maximilians - University of Munich | 25 | 2003-09-01 | 2015-09-02 |
Lymphoma (2) · Asthma (1) · Autoimmune Diseases (1) · Choroidal Effusions (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Dysferlinopathy (1) · Giant Cell Arteritis (1) · Hemangioma (1) · Inflammation (1) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Limb-girdle muscular dystrophy, type 2B (1) · Liver Diseases (1) · Lymphoma, Large B-Cell, Diffuse (1) · Miyoshi myopathy (1)
Celgene (2) · Amgen (1) · Chinese PLA General Hospital (1) · Clearside Biomedical, Inc. (1) · Dokuz Eylul University (1) · Genzyme, a Sanofi Company (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Hoffmann-La Roche (1) · Ludwig-Maximilians - University of Munich (1) · Mary-Ellen Taplin, MD (1) · NYU Langone Health (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Peking University International Hospital (1) · Queen Savang Vadhana Memorial Hospital, Thailand (1) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)
United States (11) · Canada (3) · China (3) · Germany (3) · Denmark (2) · Italy (2) · Spain (2) · United Kingdom (2) · Austria (1) · Brazil (1) · Estonia (1) · Finland (1) · France (1) · Netherlands (1) · Thailand (1)
Angeliki Kazeros, MD (1) · Aryeh Fischer, MD (1) · Celeste Bello, M.D. (1) · Corey C Ford, M.D., Ph.D. (1) · Daihong Liu (1) · David B. Badesch, M.D. (1) · Donald H Arnold, MD, MPH (1) · Dov C Goldenberg, MD (1) · Hui Gao, Doctor (1) · Lorinda Chung, MD (1) · Maggie C. Walter, MD (1) · Mark Nicolls, M.D. (1)
PMID 12081113, PMID 1991946, PMID 23406536, PMID 25035839, PMID 25091040, PMID 25161985, PMID 25320358, PMID 25925602, PMID 26432430, PMID 27683182, PMID 27980877, PMID 28012636, PMID 28386761, PMID 28639856, PMID 28963118, PMID 29885994, PMID 30623236, PMID 30632533, PMID 31056949, PMID 32134978, PMID 32960980, PMID 33651671, PMID 33856964, PMID 34107229, PMID 34107236, PMID 34826301, PMID 35103547, PMID 35123640, PMID 35503708, PMID 35668528, PMID 38829437, PMID 39438467
2015 (2), 2016 (1)